Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System
NCT02690805
·
clinicaltrials.gov ↗
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DEVICE:
MR-compatible scinti-mammography (MRI-SMM) system
Sponsor
University of California, Irvine